Interactions between Myc and MondoA transcription factors in metabolism and tumourigenesis

Neuroblastoma: Molecular Pathogenesis and Therapy

(2015) Chrystal U. Louis et al.   Annual Review of Medicine

Deregulated Myc Requires MondoA/Mlx for Metabolic Reprogramming and Tumorigenesis

(2015) Patrick A. Carroll et al.   CANCER CELL

Vemurafenib resistance reprograms melanoma cells towards glutamine dependence

(2015) Jenny E Hernandez-Davies et al.   Journal of Translational Medicine

Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP

(2015) Liangliang Shen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?

(2014) Ashleigh Allen et al.   LEUKEMIA RESEARCH

MondoA-Mlx Transcriptional Activity Is Limited by mTOR-MondoA Interaction

(2014) Mohan R. Kaadige et al.   MOLECULAR AND CELLULAR BIOLOGY

Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles

(2014) Susanne Walz et al.   NATURE

Response of BRAF-Mutant Melanoma to BRAF Inhibition Is Mediated by a Network of Transcriptional Regulators of Glycolysis

(2014) T. J. Parmenter et al.   Cancer Discovery

Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target

(2013) Luika A. Timmerman et al.   CANCER CELL

Targeting triple negative breast cancer: Is p53 the answer?

(2013) Natalie Turner et al.   CANCER TREATMENT REVIEWS

AMPK-Dependent Degradation of TXNIP upon Energy Stress Leads to Enhanced Glucose Uptake via GLUT1

(2013) Ning Wu et al.   MOLECULAR CELL

Coordination of Nutrient Availability and Utilization by MAX- and MLX-Centered Transcription Networks

(2013) J. M. O'Shea et al.   Cold Spring Harbor Perspectives in Medicine

MYC on the Path to Cancer

(2012) Chi V. Dang   CELL

Links between metabolism and cancer

(2012) C. V. Dang   GENES & DEVELOPMENT

MondoA is highly overexpressed in acute lymphoblastic leukemia cells and modulates their metabolism, differentiation and survival

(2012) Caroline M. Wernicke et al.   LEUKEMIA RESEARCH

MYC and Aggressive B-cell Lymphomas

(2011) Graham W. Slack et al.   ADVANCES IN ANATOMIC PATHOLOGY

18F-Fluorodeoxy-glucose Positron Emission Tomography Marks MYC-Overexpressing Human Basal-Like Breast Cancers

(2011) N. Palaskas et al.   CANCER RESEARCH

An extended Myc network contributes to glucose homeostasis in cancer and diabetes

(2011) Christopher et al.   Frontiers in Bioscience-Landmark

Thioredoxin-interacting Protein (Txnip) Gene Expression

(2010) Fa-Xing Yu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Glucose Controls Nuclear Accumulation, Promoter Binding, and Transcriptional Activity of the MondoA-Mlx Heterodimer

(2010) C. W. Peterson et al.   MOLECULAR AND CELLULAR BIOLOGY

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lactic Acidosis Triggers Starvation Response with Paradoxical Induction of TXNIP through MondoA

(2010) Julia Ling-Yu Chen et al.   PLoS Genetics

Distinct Thresholds Govern Myc's Biological Output In Vivo

(2008) Daniel J. Murphy et al.   CANCER CELL

Myc's broad reach

(2008) M. Eilers et al.   GENES & DEVELOPMENT

VDUP1 mediates nuclear export of HIF1α via CRM1-dependent pathway

(2007) Daesung Shin et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH